tiprankstipranks
GelStat Corporation (GSAC)
:GSAC
US Market

GelStat (GSAC) Price & Analysis

Compare
3 Followers

GSAC Stock Chart & Stats


---

Financials

Quarterly

GSAC FAQ

What was GelStat Corporation’s price range in the past 12 months?
Currently, no data Available
What is GelStat Corporation’s market cap?
GelStat Corporation’s market cap is $185.39K.
    When is GelStat Corporation’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were GelStat Corporation’s earnings last quarter?
    Currently, no data Available
    Is GelStat Corporation overvalued?
    According to Wall Street analysts GelStat Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does GelStat Corporation pay dividends?
      GelStat Corporation does not currently pay dividends.
      What is GelStat Corporation’s EPS estimate?
      GelStat Corporation’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does GelStat Corporation have?
      GelStat Corporation has 617,980,100 shares outstanding.
        What happened to GelStat Corporation’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of GelStat Corporation?
        Currently, no hedge funds are holding shares in GSAC
        ---

        Company Description

        GelStat Corporation

        GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes GelStat Migraine, Chews 2 Lose, All Natural Speed, and GelStat Speed. The company was founded on November 13, 1991 and is headquartered in Hunt Valley, MD.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Cyanotech
        Cytosorbents
        Helius Medical Technologies
        Outlook Therapeutics
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis